Ticagrelor monotherapy following percutaneous coronary intervention for acute coronary syndrome in TWILIGHT patients: still a future for aspirin?

Eur Heart J. 2021 Jul 15;42(27):2708-2709. doi: 10.1093/eurheartj/ehab037.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Acute Coronary Syndrome* / drug therapy
  • Aspirin / therapeutic use
  • Humans
  • Percutaneous Coronary Intervention*
  • Platelet Aggregation Inhibitors / adverse effects
  • Ticagrelor / therapeutic use

Substances

  • Platelet Aggregation Inhibitors
  • Ticagrelor
  • Aspirin